Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1398

1.

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Hunault CC, Mensinga TT, Böcker KB, Schipper CM, Kruidenier M, Leenders ME, de Vries I, Meulenbelt J.

Psychopharmacology (Berl). 2009 May;204(1):85-94. doi: 10.1007/s00213-008-1440-0. Epub 2008 Dec 20.

PMID:
19099294
2.

Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.

Hunault CC, Mensinga TT, de Vries I, Kelholt-Dijkman HH, Hoek J, Kruidenier M, Leenders ME, Meulenbelt J.

Psychopharmacology (Berl). 2008 Dec;201(2):171-81. doi: 10.1007/s00213-008-1260-2. Epub 2008 Aug 10.

PMID:
18695931
3.

A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.

Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Sarne Y, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E.

J Psychopharmacol. 2008 Jun;22(4):441-51. doi: 10.1177/0269881108088194.

PMID:
18635724
4.

Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.

Curran HV, Brignell C, Fletcher S, Middleton P, Henry J.

Psychopharmacology (Berl). 2002 Oct;164(1):61-70. Epub 2002 Jul 23.

PMID:
12373420
5.

Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.

Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G.

Drug Alcohol Depend. 2006 Nov 8;85(2):114-22. Epub 2006 May 24.

PMID:
16723194
6.

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.

Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR.

J Psychopharmacol. 2009 May;23(3):266-77. doi: 10.1177/0269881108092393. Epub 2008 Aug 21.

PMID:
18719045
7.

Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.

Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2002 Dec;164(4):407-15. Epub 2002 Sep 14.

PMID:
12457271
8.

Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.

Heishman SJ, Stitzer ML, Yingling JE.

Pharmacol Biochem Behav. 1989 Sep;34(1):173-9.

PMID:
2560548
9.

Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.

Böcker KB, Gerritsen J, Hunault CC, Kruidenier M, Mensinga TT, Kenemans JL.

Pharmacol Biochem Behav. 2010 Jul;96(1):67-74. doi: 10.1016/j.pbb.2010.04.008. Epub 2010 Apr 24.

PMID:
20417659
10.

Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H.

Psychopharmacology (Berl). 2002 Jun;161(4):331-9. Epub 2002 Apr 19.

PMID:
12073159
11.
12.

Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.

Hunault CC, Böcker KB, Stellato RK, Kenemans JL, de Vries I, Meulenbelt J.

Psychopharmacology (Berl). 2014 Dec;231(24):4723-33. doi: 10.1007/s00213-014-3630-2. Epub 2014 May 31.

PMID:
24879495
13.

Neurophysiological and cognitive effects of smoked marijuana in frequent users.

Hart CL, Ilan AB, Gevins A, Gunderson EW, Role K, Colley J, Foltin RW.

Pharmacol Biochem Behav. 2010 Sep;96(3):333-41. doi: 10.1016/j.pbb.2010.06.003. Epub 2010 Jun 18.

PMID:
20600251
14.

Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.

Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM.

J Pharmacol Exp Ther. 1992 Apr;261(1):114-22.

PMID:
1313866
16.

Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.

Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ.

J Anal Toxicol. 2005 Oct;29(7):607-15.

PMID:
16419389
17.

Effects of oral THC maintenance on smoked marijuana self-administration.

Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW.

Drug Alcohol Depend. 2002 Aug 1;67(3):301-9.

PMID:
12127201
18.

Behavioral pharmacokinetics of marijuana.

Barnett G, Licko V, Thompson T.

Psychopharmacology (Berl). 1985;85(1):51-6.

PMID:
2984710
19.
20.

Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.

Heishman SJ, Huestis MA, Henningfield JE, Cone EJ.

Pharmacol Biochem Behav. 1990 Nov;37(3):561-5.

PMID:
1965045

Supplemental Content

Support Center